BOLT.TA TLV
BioLight Life Sciences Ltd.
1W: +4.6%
1M: -6.5%
3M: -25.6%
YTD: -18.1%
1Y: -46.4%
3Y: -57.5%
5Y: -57.0%
₪290.10 ($0.95)
-6.30 (-2.13%)
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
Balance Sheet Trends
Total Assets
$42M
+24.3% ▲
5Y CAGR: -8.1%
Total Liabilities
$2M
-33.6% ▼
5Y CAGR: -13.8%
Shareholders Equity
$34M
+28.0% ▲
5Y CAGR: -10.3%
Cash & Investments
$24M
+75.6% ▲
5Y CAGR: -13.9%
Total Debt
$772K
+28.9% ▲
5Y CAGR: -3.6%
Net Debt
-$3M
+64.8% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $33M | $13M | $5M | $10M | $4M |
| Short-Term Investments | $245K | $4M | $250K | $4M | $20M |
| Cash & ST Investments | $34M | $18M | $9M | $13M | $24M |
| Net Receivables | $253K | $307K | $754K | $435K | $307K |
| Inventory | $0 | $0 | $0 | $0 | $0 |
| Other Current Assets | -$245K | $0 | -$414K | $0 | $0 |
| Total Current Assets | $34M | $18M | $9M | $14M | $24M |
| Property, Plant & Equip. | $3M | $3M | $4M | $4M | $4M |
| Goodwill & Intangibles | $149K | $686K | $686K | $686K | $686K |
| Long-Term Investments | $26M | $32M | $19M | $15M | $13M |
| Other Non-Current Assets | $946K | $3M | $69K | $0 | $0 |
| Total Non-Current Assets | $30M | $39M | $24M | $20M | $18M |
| Total Assets | $64M | $57M | $33M | $34M | $42M |
| — Liabilities — | |||||
| Accounts Payable | $146K | $301K | $235K | $134K | $77K |
| Short-Term Debt | $443K | $527K | $0 | $533K | $531K |
| Deferred Revenue | -$443K | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $0 | -$527K | $484K | $866K | $444K |
| Total Current Liabilities | $2M | $3M | $2M | $2M | $2M |
| Long-Term Debt | $0 | $0 | $0 | $0 | $0 |
| Other Non-Current Liab. | $0 | $0 | $0 | $0 | $0 |
| Total Non-Current Liabilities | $543K | $783K | $836K | $1M | $241K |
| Total Liabilities | $3M | $3M | $3M | $3M | $2M |
| — Equity — | |||||
| Common Stock | $11M | $11M | $12M | $12M | $23M |
| Retained Earnings | -$209M | -$217M | -$243M | -$250M | -$262M |
| Accumulated OCI | $8M | $8M | $10M | $16M | $18M |
| Total Stockholders Equity | $61M | $53M | $30M | $27M | $34M |
| Total Liabilities & Equity | $64M | $57M | $33M | $34M | $42M |
| — Key Metrics — | |||||
| Total Debt | $443K | $527K | $91K | $599K | $772K |
| Net Debt | -$33M | -$13M | -$5M | -$9M | -$3M |
| Total Investments | $26M | $36M | $20M | $19M | $33M |